The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Singular Genomics Systems Inc (OMIC) shows that investor sentiment remained same, with the stock’s consolidated last price to $0.58. The Singular Genomics Systems Inc has recorded 114,545 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Singular Genomics to Report Third Quarter 2023 Financial Results on November 14, 2023.
Singular Genomics Systems Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Medical Instruments & Supplies industry. At the end of the last regular session, the stock closed at $0.58 and fluctuated between $0.6090 as its day high and $0.5020 as its day low. The current market capitalization of Singular Genomics Systems Inc is $42.42M. A total of 5.12 million shares were traded on the day, compared to an average of 389.17K shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, OMIC has seen 5 BUY and 4 SELL insider trades, representing the acquisition of 47,105 and the disposition of 646,232 shares. Over the last 12 months, there were 12 BUYs and 5 SELLs from insiders. Insiders purchased 314,209 shares during that period but sold 660,815.
In the most recent transaction, Kamdar Kim P. sold 200,000 shares of OMIC for 0.53 per share on Aug 15. After the transaction, the Director now owns 3,763,985 company shares. In a previous transaction on Aug 14, Kamdar Kim P. sold 77,991 shares at 0.57 per share. OMIC shares that Director owns now total 3,963,985.
Among the insiders who sold shares, Kamdar Kim P. disposed of 353,657 shares on Aug 11 at a per-share price of $0.60. This resulted in the Director holding 4,041,976 shares of OMIC after the transaction. In another insider transaction, Glezer Eli N. bought 170,000 shares at $0.82 per share on May 17. Company shares held by the Chief Scientific Officer now total 4,355,000.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for OMIC in the last 3 months, the mean price target is $0.70 with high estimates of $1.00 and low estimates of $0.40. In terms of 52-week highs and lows, OMIC has a high of $3.00 and a low of $0.31.
As of this writing, OMIC has an earnings estimate of -$0.38 per share for the current quarter. EPS was calculated based on a consensus of 3 estimates, with a high estimate of -$0.37 per share and a lower estimate of -$0.39. The company reported an EPS of -$0.33 in the last quarter, which was 5.70% higher than expectations of -$0.35.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. OMIC’s latest balance sheet shows that the firm has $339.22M in Cash & Short Term Investments as of fiscal 2021. There were $9.90M in debt and $6.74M in liabilities at the time. Its Book Value Per Share was $2.99, while its Total Shareholder’s Equity was $336.17M.
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for OMIC is Buy with a score of 3.25.